Wegovy Weight Loss Results UK - From £124.99 | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy UK Price - From £124.99

Get Wegovy at the cheapest UK price from £124.99 — Save £20 with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Wegovy Weight Loss Results UK: What to Expect from Clinical Trials and Real Patient Outcomes

Wegovy weight loss results UK patients can expect are backed by extensive clinical evidence showing significant, sustained weight reduction when combined with lifestyle modifications. As a UK-registered pharmacy with over a decade of experience dispensing semaglutide-based treatments, we've seen firsthand how Wegovy transforms weight management journeys for thousands of patients. Understanding the realistic timeline, average outcomes, and factors influencing individual results helps set appropriate expectations before starting treatment.

Clinical Trial Data: Wegovy Weight Loss Results UK Patients Can Reference

The STEP clinical trial programme provides the most comprehensive evidence for Wegovy weight loss results UK prescribers and patients rely upon. In the pivotal STEP 1 trial involving 1,961 adults without diabetes, participants taking Wegovy 2.4mg weekly achieved an average weight reduction of 14.9% of their initial body weight over 68 weeks, compared to just 2.4% with placebo[1]. This translates to approximately 15.3kg (33.7 pounds) of weight loss for someone starting at 105kg.

Importantly, 86.4% of Wegovy-treated participants achieved at least 5% weight loss — the threshold considered clinically meaningful — whilst 69.1% achieved 10% or greater reduction, and 50.5% lost 15% or more[1]. These results demonstrate that whilst individual outcomes vary, the majority of patients experience substantial weight reduction when adherent to the full 2.4mg maintenance dose. The trial required participants to follow a reduced-calorie diet and increase physical activity, underscoring that Wegovy works synergistically with lifestyle changes rather than replacing them.

The STEP 2 trial specifically examined Wegovy weight loss results in adults with type 2 diabetes, showing an average 9.6% body weight reduction at 68 weeks[2]. Whilst slightly lower than results in the non-diabetic population, this still represents meaningful weight loss that improves glycaemic control, cardiovascular risk factors, and quality of life. UK patients with diabetes prescribed Wegovy should anticipate gradual, sustained results over 12-16 months of treatment.

Realistic Timeline: When Wegovy Weight Loss Results UK Patients Notice Changes

Wegovy follows a carefully structured dose-escalation schedule designed to minimise gastrointestinal side effects whilst building towards the therapeutic 2.4mg weekly dose. Most UK patients begin noticing weight changes during the first 4-8 weeks, though results during this initial phase are modest as doses remain sub-therapeutic. The starting dose of 0.25mg weekly increases monthly through 0.5mg, 1mg, and 1.7mg before reaching the maintenance 2.4mg dose at week 17.

Peak Wegovy weight loss results UK clinical data shows typically occur between months 6-12 of treatment, with the majority of total weight reduction achieved by 68 weeks[1]. During months 1-4, expect gradual losses of 1-2% of body weight as doses escalate. Months 5-8 generally see accelerated results as patients reach higher therapeutic doses, with 5-8% total reduction common by this stage. The final maintenance phase from months 9-16 produces the remaining weight loss, bringing total average reduction to the 15% range observed in trials.

Individual Variation in Wegovy Weight Loss Results UK Patients Experience

Whilst clinical trial averages provide useful benchmarks, individual Wegovy weight loss results UK patients achieve vary considerably based on adherence, baseline metabolic health, dietary quality, physical activity levels, sleep patterns, and genetic factors. Approximately 15% of trial participants did not achieve the 5% threshold considered clinically meaningful[1], whilst others exceeded 20% body weight reduction. Factors associated with superior outcomes include strict adherence to the weekly injection schedule, consistent calorie deficit maintenance, regular physical activity exceeding 150 minutes weekly, and absence of medications that promote weight gain.

Age, sex, and baseline BMI also influence results. Post-menopausal women and patients with very high starting BMI (>40 kg/m²) may experience slightly slower initial progress but often achieve substantial total reduction with extended treatment. The key predictor of success remains consistency — patients who maintain Wegovy treatment for the full 68-week period and implement concurrent lifestyle modifications achieve significantly better outcomes than those who discontinue prematurely or rely solely on medication without dietary changes.

Comparing Wegovy Weight Loss Results UK Data Against Other GLP-1 Treatments

When evaluating Wegovy weight loss results UK patients should understand how semaglutide 2.4mg compares to alternative GLP-1 receptor agonists and weight management medications. Saxenda (liraglutide 3mg daily) produces average weight loss of 8% over 56 weeks[3], approximately half the reduction seen with Wegovy despite requiring daily rather than weekly injections. This difference reflects semaglutide's superior receptor binding affinity and extended half-life, allowing once-weekly dosing whilst maintaining therapeutic drug levels.

Tirzepatide (Mounjaro), a dual GIP/GLP-1 receptor agonist, demonstrates even more impressive results in the SURMOUNT trials, with average weight reduction of 20.9% at the 15mg dose over 72 weeks[4]. However, Wegovy remains the most extensively studied weight management medication in the UK market, with robust long-term safety data and established NHS prescribing pathways. For most patients, Wegovy offers an optimal balance of efficacy, tolerability, and clinical evidence supporting sustained weight maintenance.

Treatment Type Frequency Starting Price
Wegovy (Semaglutide) GLP-1 injection Weekly from £89.00
Mounjaro (Tirzepatide) GIP/GLP-1 injection Weekly from £145.00
Saxenda (Liraglutide) GLP-1 injection Daily from £68.00
Wegovy Oral Tablets GLP-1 tablet Daily from £83.00
Orlistat Fat absorption inhibitor Three times daily from £32.00

Maintaining Wegovy Weight Loss Results UK Patients Achieve Long-Term

The STEP 4 trial specifically examined weight maintenance after achieving initial Wegovy weight loss results UK patients can reference when considering long-term treatment. Participants who reached the 2.4mg dose after 20 weeks were randomised to either continue Wegovy or switch to placebo. Those continuing Wegovy maintained their weight loss and achieved an additional 7.9% reduction over the subsequent 48 weeks, whilst the placebo group regained 6.9% of their body weight[5].

This data demonstrates that Wegovy requires ongoing treatment to sustain results — discontinuation typically leads to gradual weight regain as the medication's appetite-suppressing and metabolic effects diminish. UK prescribers generally recommend indefinite continuation for patients who tolerate Wegovy well and achieve meaningful weight loss, similar to management approaches for other chronic conditions like hypertension or diabetes. The medication works by modulating appetite signalling pathways in the brain, effects that reverse when treatment stops.

Strategies to Optimise Long-Term Wegovy Weight Loss Results UK Experts Recommend

Maximising sustained Wegovy weight loss results UK patients achieve requires integrating evidence-based lifestyle modifications alongside pharmacotherapy. Prioritise protein intake of 1.2-1.6g per kilogram of ideal body weight daily to preserve lean muscle mass during weight reduction, as trials show approximately 25-30% of weight lost can come from muscle if protein intake is inadequate. Resistance training 2-3 times weekly further protects metabolic rate by maintaining muscle tissue.

Regular monitoring with your prescriber helps identify plateaus early and adjust strategies accordingly. Some patients benefit from periodic diet breaks or refeeds to prevent metabolic adaptation, whilst others require evaluation for underlying conditions like hypothyroidism or sleep apnoea that can impair weight loss. Behavioural strategies including food logging, regular weigh-ins, stress management, and adequate sleep (7-9 hours nightly) all correlate with superior long-term outcomes in weight management research.

Safety Profile and Side Effects Influencing Wegovy Weight Loss Results UK Patients Report

Understanding Wegovy's side effect profile helps patients maintain treatment adherence necessary for optimal weight loss results. The most common adverse effects are gastrointestinal: nausea (44% of participants), diarrhoea (30%), vomiting (24%), and constipation (24%)[1]. These typically emerge during dose escalation phases and diminish over 4-8 weeks as the body adapts. Eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated helps manage these symptoms.

Serious adverse events remain rare but require awareness. Wegovy carries warnings regarding thyroid C-cell tumours (based on rodent studies), pancreatitis risk, gallbladder disease, and potential worsening of diabetic retinopathy in patients with pre-existing disease[1]. UK prescribers screen for contraindications including personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 before initiating treatment. Patients experiencing severe abdominal pain, persistent vomiting, or visual changes should seek immediate medical assessment.

Accessing Wegovy Weight Loss Results UK Patients Achieve Through Cured Pharmacy

Cured Pharmacy offers Wegovy from £124.99 with transparent upfront pricing and a streamlined online consultation process completed in under 3 minutes by UK-registered prescribers. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team have supported thousands of weight management journeys, ensuring patients receive comprehensive guidance on maximising Wegovy weight loss results UK clinical standards require. All consultations assess medical history, current medications, contraindications, and suitability for GLP-1 therapy before prescribing.

We supply genuine UK-licensed Wegovy in discreet packaging with next-day delivery options, eliminating the extended waiting times often encountered through traditional GP pathways. New patients receive £20 off their first order using code Weightlossnew, making evidence-based weight management more accessible. Our clinical team provides ongoing support throughout your treatment journey, helping troubleshoot side effects, adjust lifestyle strategies, and monitor progress towards your weight loss goals. All prescription medications require clinical assessment and approval by a UK-registered prescriber before dispensing.

Why Choose Cured Pharmacy for Your Wegovy Weight Loss Results UK Journey

As a fully registered UK pharmacy (GPhC 9012511), Cured Pharmacy combines clinical expertise with competitive pricing and patient-centred service. Unlike high-street pharmacies with limited stock availability, we maintain consistent Wegovy supply and offer price matching guarantees ensuring you receive the lowest UK price. Our transparent pricing model shows exact costs before consultation, eliminating surprise fees or hidden charges common with some online providers.

We understand that achieving optimal Wegovy weight loss results UK patients desire requires more than just dispensing medication — it demands ongoing clinical support, evidence-based lifestyle guidance, and accessible expert advice. Our pharmacist-led team remains available via phone (+44 116 4646009) or online messaging to address questions, provide injection technique guidance, and support your weight management journey from initial consultation through long-term maintenance. Every patient receives personalised care reflecting our commitment to improving health outcomes across the UK.

Scientific References

  1. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., ... & Lingvay, I. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. [accessed 15 August 2026]
  3. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & Wilding, J. P. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22. [accessed 15 August 2026]
  4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
  5. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
  6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

What are typical Wegovy weight loss results UK patients achieve in the first 3 months?
Most UK patients lose 5-8% of their starting body weight during the first 3 months on Wegovy as doses escalate towards the therapeutic 2.4mg maintenance level. Individual results vary based on adherence, diet quality, and physical activity levels.
How do Wegovy weight loss results UK clinical trials show compare to real-world outcomes?
Real-world UK data generally mirrors clinical trial results, with most adherent patients achieving 10-15% body weight reduction over 12-16 months. Outcomes depend heavily on lifestyle modification consistency and treatment adherence throughout the dose escalation and maintenance phases.
Can I expect Wegovy weight loss results UK patients report without changing my diet?
Wegovy works most effectively when combined with a reduced-calorie diet and increased physical activity, as required in all clinical trials. Relying solely on medication without lifestyle changes typically produces inferior results compared to the comprehensive approach used in STEP trials.
When do peak Wegovy weight loss results UK data shows typically occur?
Peak weight loss generally occurs between months 6-12 of treatment, with most patients reaching the therapeutic 2.4mg dose by week 17 and achieving maximum reduction by 68 weeks as demonstrated in clinical trials.
What percentage of patients achieve significant weight loss on Wegovy?
In the STEP 1 trial, 86.4% of participants achieved at least 5% weight loss, 69.1% lost 10% or more, and 50.5% achieved 15% or greater reduction. Individual outcomes vary based on adherence and lifestyle factors.
Do Wegovy weight loss results UK patients achieve last after stopping treatment?
Clinical trials show most patients regain significant weight after discontinuing Wegovy, with the STEP 4 trial demonstrating 6.9% weight regain over 48 weeks post-discontinuation. Ongoing treatment is typically required to maintain results long-term.
How quickly will I notice weight changes after starting Wegovy?
Most patients notice initial weight changes within 4-8 weeks, though early results are modest as starting doses remain sub-therapeutic. More substantial reduction occurs after reaching higher doses from month 5 onwards during the escalation schedule.
Are Wegovy weight loss results better than other GLP-1 medications available in the UK?
Wegovy produces superior weight loss compared to Saxenda (8% average reduction) but slightly less than Mounjaro's dual GIP/GLP-1 mechanism (20.9% at highest dose). Wegovy offers the most extensive long-term safety data among weekly GLP-1 treatments in the UK market.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.